Table of Contents
Chapter 1. Global Closed System Drug Transfer Device (CSTD) Market Executive Summary
1.1. Global Closed System Drug Transfer Device (CSTD) Market Size & Forecast (2022-2032)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Type
1.3.2. By Closing Mechanism
1.3.3. By Component
1.3.4. By Technology
1.3.5. By End User
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion
Chapter 2. Global Closed System Drug Transfer Device (CSTD) Market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Consumer's Perspective)
2.3.4. Demand Side Analysis
2.3.4.1. Regulatory Frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
Chapter 3. Global Closed System Drug Transfer Device (CSTD) Market Dynamics
3.1. Market Drivers
3.1.1. Increasing Use of Hazardous Drugs
3.1.2. Growing Oncology Services
3.2. Market Challenges
3.2.1. High Cost of CSTDs
3.2.2. Limited Awareness in Emerging Markets
3.3. Market Opportunities
3.3.1. Technological Advancements in CSTDs
3.3.2. Expansion in Home Healthcare Services
3.3.3. Growing Geriatric Population
Chapter 4. Global Closed System Drug Transfer Device (CSTD) Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model
4.1.7. Porter's 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top Investment Opportunity
4.4. Top Winning Strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Global Closed System Drug Transfer Device (CSTD) Market Size & Forecasts by Type 2022-2032
5.1. Segment Dashboard
5.2. Global Closed System Drug Transfer Device (CSTD) Market: Type Revenue Trend Analysis, 2022 & 2032 (USD Million)
5.2.1. Barrier Type
5.2.2. Filtration Type
Chapter 6. Global Closed System Drug Transfer Device (CSTD) Market Size & Forecasts by Closing Mechanism 2022-2032
6.1. Segment Dashboard
6.2. Global Closed System Drug Transfer Device (CSTD) Market: Closing Mechanism Revenue Trend Analysis, 2022 & 2032 (USD Million)
6.2.1. Push to Turn System
6.2.2. Color-to-Color Alignment System
6.2.3. Leur Lock Systems
6.2.4. Others
Chapter 7. Global Closed System Drug Transfer Device (CSTD) Market Size & Forecasts by Component 2022-2032
7.1. Segment Dashboard
7.2. Global Closed System Drug Transfer Device (CSTD) Market: Component Revenue Trend Analysis, 2022 & 2032 (USD Million)
7.2.1. Vial Access Devices
7.2.2. Syringe Safety Devices
7.2.3. Bag/Infusion Set Devices
7.2.4. Others
Chapter 8. Global Closed System Drug Transfer Device (CSTD) Market Size & Forecasts by Technology 2022-2032
8.1. Segment Dashboard
8.2. Global Closed System Drug Transfer Device (CSTD) Market: Technology Revenue Trend Analysis, 2022 & 2032 (USD Million)
8.2.1. Compartmentalize Devices
8.2.2. Diaphragm-based Devices
8.2.3. Air Filtration Devices
Chapter 9. Global Closed System Drug Transfer Device (CSTD) Market Size & Forecasts by End User 2022-2032
9.1. Segment Dashboard
9.2. Global Closed System Drug Transfer Device (CSTD) Market: End User Revenue Trend Analysis, 2022 & 2032 (USD Million)
9.2.1. Hospitals & Clinics
9.2.2. Specialty Centers
9.2.3. Others
Chapter 10. Global Closed System Drug Transfer Device (CSTD) Market Size & Forecasts by Region 2022-2032
10.1. North America Closed System Drug Transfer Device (CSTD) Market
10.1.1. U.S. Closed System Drug Transfer Device (CSTD) Market
10.1.1.1. Type breakdown size & forecasts, 2022-2032
10.1.1.2. Closing Mechanism breakdown size & forecasts, 2022-2032
10.1.1.3. Component breakdown size & forecasts, 2022-2032
10.1.1.4. Technology breakdown size & forecasts, 2022-2032
10.1.1.5. End User breakdown size & forecasts, 2022-2032
10.1.2. Canada Closed System Drug Transfer Device (CSTD) Market
10.2. Europe Closed System Drug Transfer Device (CSTD) Market
10.2.1. U.K. Closed System Drug Transfer Device (CSTD) Market
10.2.2. Germany Closed System Drug Transfer Device (CSTD) Market
10.2.3. France Closed System Drug Transfer Device (CSTD) Market
10.2.4. Spain Closed System Drug Transfer Device (CSTD) Market
10.2.5. Italy Closed System Drug Transfer Device (CSTD) Market
10.2.6. Rest of Europe Closed System Drug Transfer Device (CSTD) Market
10.3. Asia-Pacific Closed System Drug Transfer Device (CSTD) Market
10.3.1. China Closed System Drug Transfer Device (CSTD) Market
10.3.2. India Closed System Drug Transfer Device (CSTD) Market
10.3.3. Japan Closed System Drug Transfer Device (CSTD) Market
10.3.4. Australia Closed System Drug Transfer Device (CSTD) Market
10.3.5. South Korea Closed System Drug Transfer Device (CSTD) Market
10.3.6. Rest of Asia Pacific Closed System Drug Transfer Device (CSTD) Market
10.4. Latin America Closed System Drug Transfer Device (CSTD) Market
10.4.1. Brazil Closed System Drug Transfer Device (CSTD) Market
10.4.2. Mexico Closed System Drug Transfer Device (CSTD) Market
10.4.3. Rest of Latin America Closed System Drug Transfer Device (CSTD) Market
10.5. Middle East & Africa Closed System Drug Transfer Device (CSTD) Market
10.5.1. Saudi Arabia Closed System Drug Transfer Device (CSTD) Market
10.5.2. South Africa Closed System Drug Transfer Device (CSTD) Market
10.5.3. Rest of Middle East & Africa Closed System Drug Transfer Device (CSTD) Market
Chapter 11. Competitive Intelligence
11.1. Key Company SWOT Analysis
11.2. Top Market Strategies
11.3. Company Profiles
11.3.1. Becton, Dickinson and Company
11.3.1.1. Key Information
11.3.1.2. Overview
11.3.1.3. Financial (Subject to Data Availability)
11.3.1.4. Product Summary
11.3.1.5. Market Strategies
11.3.2. BRAUN SE
11.3.3. Epic Medical
11.3.4. JMS Co. Ltd
11.3.5. Equashield
11.3.6. ICU Medical, Inc
11.3.7. Yukon Medical
11.3.8. Simplivia Healthcare, Ltd.
11.3.9. Caragen Ltd
11.3.10. Corvida Medical
11.3.11. Baxter International Inc.
11.3.12. Teva Pharmaceutical Industries Ltd.
11.3.13. Pfizer Inc.
11.3.14. Novartis AG
11.3.15. Sanofi S.A.
Chapter 12. Research Process
12.1. Research Process
12.1.1. Data Mining
12.1.2. Analysis
12.1.3. Market Estimation
12.1.4. Validation
12.1.5. Publishing
12.2. Research Attributes